{"id":"W4402560803","doi":"10.1016/j.annonc.2024.08.968","title":"907P Biomarker analysis of the phase III KEYNOTE-040 study of pembrolizumab (pembro) versus methotrexate, docetaxel, or cetuximab (SOC) for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cetuximab; Docetaxel; Pembrolizumab; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Pemetrexed; Head and neck cancer; Radiation therapy; Cancer; Chemotherapy; Cisplatin; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003742863,0.001203076,0.001676086,0.0003514256,0.0003374053,0.001467956,0.0009315126,0.001010912,0.003924326],"category_scores_gemma":[0.002550796,0.000660972,0.002039755,0.0004692439,0.0007351783,0.0009855129,0.0007832779,0.002343696,0.001066802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001364413,"about_ca_system_score_gemma":0.001665642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001384888,"about_ca_topic_score_gemma":0.002884416,"domain_scores_codex":[0.9987865,0.000691534,0.00004419564,0.0001982552,0.0001534414,0.0001260275],"domain_scores_gemma":[0.9988766,0.0002394257,0.0003479539,0.0001124661,0.0001239627,0.0002996196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8317164,0.007456673,0.0417272,0.001081044,0.0125694,0.0001654971,0.0001677865,0.003256681,0.03011549,0.0006406071,0.009083432,0.06201968],"study_design_scores_gemma":[0.4924347,0.2538533,0.2008145,0.0001708939,0.0175679,0.0009172001,0.0002629193,0.003635829,0.01308375,0.001135363,0.01599065,0.000133115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888988,0.002949059,0.0004147124,0.0007601179,0.0001661413,0.0005523647,0.00430501,0.00008101478,0.001872904],"genre_scores_gemma":[0.987335,0.00104726,0.001245931,0.0007890709,0.00009519351,0.0005620063,0.006809567,0.00004149568,0.002074627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003924326,"threshold_uncertainty_score":0.01979434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1842249064878339,"score_gpt":0.4631268314667685,"score_spread":0.2789019249789347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}